Cancer Diagnostics Market to Reach $232.7 Billion by 2025 - Key Vendors are GE Healthcare, Abbott, Hoffmann-La Roche & Siemens Healthcare - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2014 - 2025" report to their offering.

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.

Companies Mentioned

  • Abbott
  • Qiagen
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Hologic,Inc.
  • Becton, Dickinson and Company
  • Koninklijke Philips N.V.
  • Illumina, Inc.

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Cancer Diagnostics Market Variables, Trends & Scope

4 Cancer Diagnostics: Screening Type Estimates & Trend Analysis

5 Cancer Diagnostics: Application Estimates & Trend Analysis

6 Cancer Diagnostics: Regional Estimates &Trend Analysis, by Screening Type & Application Type

7 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/mpgnmq/cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics